Le Lézard
Classified in: Science and technology, Business
Subjects: MAV, ERN, CCA

/R E P E A T -- Conference call for the release of the consolidated results of Quebecor Inc. for the fourth quarter 2019 and full year 2019/


MONTREAL, Feb. 27, 2020 /CNW Telbec/ - Pierre Karl Péladeau, President and Chief Executive Officer, Quebecor Inc. and Quebecor Media Inc., Jean-François Pruneau, President and Chief Executive Officer, Videotron Ltd., France Lauzière, President and Chief Executive Officer, TVA Group Inc. and Chief of Content, Quebecor Content, and Hugues Simard, Chief Financial Officer, Quebecor Inc. and Quebecor Media Inc., will hold a conference call on Thursday, March 12, 2020, at 11 AM, following the release of Quebecor Inc.'s consolidated results for the fourth quarter 2019 and full year 2019.

 

Conference call:

Quebecor Inc. reports fourth quarter 2019 and full year 2019 consolidated results


Thursday, March 12, 2020, at 11 AM



Call-in number:

1-877-293-8052 (Canada-US)

Participant code:

48006#



Speakers:

Pierre Karl Péladeau, President and Chief Executive Officer, Quebecor Inc. and Quebecor Media Inc.;




Jean-François Pruneau, President and Chief Executive Officer, Videotron Ltd.;




France Lauzière, President and Chief Executive Officer, TVA Group Inc. and Chief of Content, Quebecor Content;




Hugues Simard, Chief Financial Officer, Quebecor Inc. and Quebecor Media Inc.



Attending:

Denis Sabourin, Vice President and Corporate Controller, Quebecor Inc. and Quebecor Media Inc.


 

Anyone unable to attend this conference call may listen to the rebroadcast by phoning 1-877-293-8133 (Canada-US), conference access code 48006# and playback access code 48006# (available until June 11, 2020).

The conference call is also available in audio webcast on Quebecor's website at 
www.quebecor.com/en/investors/conferences-and-annual-meeting#Next-earnings-call

The Company
Quebecor, a Canadian leader in telecommunications, entertainment, news media and culture, is one of the best-performing integrated communications companies in the industry. Driven by their determination to deliver the best possible customer experience, all of Quebecor's subsidiaries and brands are differentiated by their high-quality, multiplatform, convergent products and services.

Québec-based Quebecor (TSX: QBR.A, QBR.B) employs more than 10,000 people in Canada.

A family business founded in 1950, Quebecor is strongly committed to the community. Every year, it actively supports more than 400 organizations in the vital fields of culture, health, education, the environment and entrepreneurship.

Visit our website: www.quebecor.com
Follow us on Twitter: twitter.com/Quebecor

SOURCE Quebecor


These press releases may also interest you

at 06:05
Zura Bio Limited ("Zura Bio") a clinical-stage immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases, today reported full year 2023 financial results and recent business highlights. The Company has also...

at 06:05
REX American Resources Corporation ("REX" or the "Company") , a leading ethanol production company, today announced financial and operational results for the Company's full year and fiscal fourth quarter 2023. REX American Resources' Q4 and full...

at 06:05
Calibre Mining Corp. ("Calibre" or the "Company") is pleased to announce the Company has entered into a key pre-commissioning and commissioning contract with Reliable Controls Corporation of Salt Lake City ("RCC") for the Company's Valentine Gold...

at 06:00
Canada's construction sector experienced a slight contraction in 2023, as growth in the non-residential sector was offset by a moderate decline in activity in the residential sector. Despite this trend, the industry continues to perform at an...

at 06:00
Stallion Uranium Corp. (the "Company" or "Stallion") is pleased to announce that it has appointed Matthew Schwab, an acclaimed exploration geologist in the Athabasca Basin, to its Board of Directors. At the same time, the Company thanks Terry Wells...

at 06:00
Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, today announced the appointment of Dr. Neil Gallagher to...



News published on and distributed by: